| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | -76.1% |
| R&D Expense | $18.4M | -70.1% |
| SG&A Expense | $18.5M | -34.3% |
| Operating Income | -$35.5M | +60.4% |
| Income Tax | $0 | — |
| Net Income | -$34.7M | +61.2% |
| EPS (Basic) | -$0.87 | -24.3% |
| EPS (Diluted) | -$0.87 | -24.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $210.5M | -17.1% |
| Short-term Investments | $63.9M | — |
| Current Assets | $277.7M | +6.2% |
| Total Assets | $281.4M | -15.6% |
| Current Liabilities | $5.4M | -63.4% |
| Total Liabilities | $8.5M | -56.5% |
| Stockholders' Equity | $272.9M | -13.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.1M | +40.0% |
| Capital Expenditures | $199K | -85.5% |
| Investing Cash Flow | -$199K | +99.7% |
| Financing Cash Flow | $190.7M | — |
| Free Cash Flow | -$40.3M | +40.9% |